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New Approach for Combined
arotid and Coronary Disease
he SHARP Study*
ohn G. Byrne, MD, Mark A. Robbins, MD,
arzia Leacche, MD
ashville, Tennessee
hybrid strategy combines the treatments traditionally
vailable only in the catheterization laboratory (cath lab)
ith those traditionally available only in the operating room
OR), to offer patients the best available combination of
reatments for any given set of cardiovascular lesions.
See page 393
ardiac surgeons and interventional cardiologists have been
erforming hybrid procedures since the first percutaneous
ntervention was followed later (perhaps several days or
onths later) by a traditional cardiac surgical procedure. In
he modern era, a hybrid procedure refers to the combina-
ion of traditional surgery and percutaneous intervention—
taged by minutes, hours, or at most, days—typically during
he same hospital stay. This more compressed staging
f hybrid procedures is the subject of the report by Versaci
t al. (1).
efinitions
ecause the sequence and timing of each procedure is
ecoming more important, it might be helpful to define the
taging, on the basis of how much time and space separates
he 2 procedures. The 2 procedures can be separated by 2
ifferent hospital stays in a planned treatment strategy
“2-hospitalization hybrid”), they can be separated by 2
ifferent days during the same hospital stay (“1-
ospitalization hybrid”), they can be separated by 2 different
rocedural suites during the same day (“same day hybrid”),
r they can be separated by minutes when the 2 procedures
re performed in a combined hybrid cath lab/OR (“true
ybrid”). The study by Versaci et al. evaluates a “same-day
Editorials published in JACC: Cardiovascular Interventions reflect the views of the
uthors and do not necessarily represent the views of JACC: Cardiovascular Interven-h
ions or the American College of Cardiology.
From The Vanderbilt Heart & Vascular Institute, Nashville, Tennessee.ybrid” strategy for the treatment of combined carotid
rtery and coronary artery disease (CAD).
hy Hybrid Procedures Matter
ith the increased complexity of patients referred to the
ath lab and to surgery, a team approach combining the best
vailable tools of both specialties seems appealing to mini-
ize the procedural risk. We and others have documented
mproved patient outcomes when this approach is used in
elected patients (2). Examples of hybrid strategies include
ybrid coronary artery bypass grafting (CABG)/percuta-
eous coronary intervention, hybrid valve/percutaneous
oronary intervention, and hybrid CABG/carotid artery
tenting (CAS), the subject of the Versaci’s report (1).
ackground
arge trials have shown the efficacy of carotid endarterec-
omy (CEA) for the prevention of stroke in symptomatic as
ell as asymptomatic patients with severe carotid artery
tenosis (3,4). In CEA patients with concomitant signifi-
ant CAD, the risk of perioperative myocardial infarction
nd early and late death are increased. Conversely, in
atients undergoing CABG, uncorrected severe carotid
isease increases the risk of adverse neurologic events (5).
he optimal management of these co-existing conditions
nd the timing and sequence of correcting them remain
ontroversial. Over the past 2 decades, staged CEA fol-
owed by CABG, staged CABG followed by CEA, or
ombined CABG/CEA in 1 operative setting have each
een advocated.
hat Makes Versaci’s Study Unique
n the modern era, CAS has emerged as an alternative to
urgical CEA for the treatment of severe carotid disease. A
ecent meta-analysis of 8 trials, analyzing 2,942 patients,
omparing CAS versus CEA documented that CAS and
EA had similar risk of stroke or death (6). Thus, in
atients with co-existing CAD and carotid disease, a staged
pproach with either CAS or CABG performed first fol-
owed later (typically during a different hospital stay) by the
ther procedure (“2-hospitalization hybrid”) or CABG/
AS performed on 2 separate days in 1 hospital setting
“1-hospitalization hybrid”) has become an alternative in
hese patients. In a study comparing CAS followed later
same hospital stay) by CABG versus combined single-stage
urgical CABG/CEA, after propensity score match, the
dverse events (death, stroke, or myocardial infarction) were
imilar for both procedures despite the CAS followed by
ABG group being higher risk (7). Versaci et al. (1) have
ompressed the staging further by performing “same-day
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403ver, because the 2 procedures were not “simultaneous” (as
s possible only in “true hybrid” using a combined hybrid
ath lab/OR) but rather “same-day,” separated by hours
ith 2 separate operative suites during the same day. That
s, immediately after CAS, the patients were transferred to
he OR for on-pump CABG. This strategy is suggested to
educe the risks of cardiac events while awaiting CABG.
oreover, most patients prefer 1 procedural day rather than
and certainly prefer 1 hospital stay rather than 2.
iscussion
arotid artery stenting can be performed without general
nesthesia, so that neurologic status can be monitored
uring the procedure. This is especially appealing in patients
ho need CABG the same day, because stroke is a known
isk of CABG regardless of the status of the carotid arteries.
Versaci et al. (1) confirm that “same-day” CAS/CABG is
afe and feasible with very good perioperative outcomes.
he authors report this “same-day hybrid” approach in 101
onsecutive patients with severe combined carotid and
oronary disease. Of the 101 patients, 55% had bilateral
arotid artery stenosis but only 15% were symptomatic. Two
2%) patients suffered a stroke after CAS, and 2 (2%)
atients died. Some questions remain, such as the timing of
ntiplatelet agents as well as the potential nephrotoxic effects of
ngiographic contrast—used for CAS—immediately before
ABG. We and others (8), however, have shown these do
ot pose major adverse risks.
Versaci’s study does not address which subset of CABG
atients benefit most by use of CAS versus CEA before or
uring CABG or whether off-pump CABG combined with
AS can further reduce complications. Also, the authors do
ot address the idea of a “true hybrid,” that is, a combined
rocedure in a hybrid cath lab/OR. In such a multipurpose
ardiovascular operating suite, patients can undergo CAS
ollowed immediately—within minutes, in the same opera-
ive setting—by both procedures (8). This improves effi-
iency, reduces cost, and might help reduce the risks of
atient transfers and hand-offs. sThe authors, however, should be congratulated for com-
ining the different tools available to the cardiovascular
urgeon and interventionalist in treating patients with com-
ined complex CAD and carotid disease. We agree with
his “combined tool box” approach, to meet the needs of an
ncreasingly complex patient population (9).
eprint requests and correspondence: Dr. John G. Byrne,
epartment of Cardiac Surgery, Vanderbilt University Medical
enter, Nashville, Tennessee 37232-8802. E-mail: john.byrne@
anderbilt.edu.
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